(lp0
S'Biocept and Catalyst Pharmaceuticals Collaborate to Provide Liquid Biopsy ... PR Newswire  - Mar 14, 2017 SAN DIEGO, March 14, 2017 /PRNewswire/ -- Biocept, Inc. , a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to improve the outcomes of cancer patients, announces a&nbsp;...Biocept  Enters Collaboration to Provide Liquid Biopsy Testing for Small ... - StreetInsider.com'
p1
aS'Valeant Pharmaceuticals Intl Inc  Running Low On Gas, Biocept Inc (BIOC ... Smarter Analyst - Mar 8, 2017 In the biotech-verse, Valeant Pharmaceuticals Intl Inc  and Biocept Inc  are in opposite standing. According to one of the best analysts on the Street, who has lately been zooming in with a vengeance on the troubled biotech giant ...Wall Street Movers News  Valeant Pharmaceuticals Intl Inc , Biocept ... - Wall Street Times '
p2
aS'Biocept to Release 2016 Fourth Quarter and Full Year Financial Results and ... PR Newswire  - Feb 21, 2017 SAN DIEGO, Feb. 21, 2017 /PRNewswire/ -- Biocept, Inc. , a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to improve the outcomes of cancer patients, announces that ...'
p3
aS"Biocept Inc  Scores Blue Cross Texas, Up 100% Insider Financial - Jan 11, 2017 Biocept Inc  gained more than 77% during Tuesday's session this week, and is up more than 100% on last week's close, on news that the company has picked up a fresh round of insurance coverage for its lead biopsy product.Stock Update : Here's Why Biocept Inc Shares Jumped 60% - Smarter AnalystBiocept, Inc.  Closed last trading session at $1.81 - TopChronicle"
p4
aS'Biocept Reports Fourth Quarter and Full Year 2016 Financial Results PR Newswire  - Mar 7, 2017 SAN DIEGO, March 7, 2017 /PRNewswire/ -- Biocept, Inc. , a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to improve the outcomes of cancer patients, reports ...'
p5
aS'Biocept Inc  Stockholders Get Letter From The CEO Journal Transcript - Feb 27, 2017 A letter sent by the Michael Nall, the chief executive officer of Biocept Inc , to shareholders has sought to underscore the strong position the pharmaceutical company is currently in, in the area of liquid biopsy.'
p6
aS'Biocept Inc  Lifted to Buy at Zacks Investment Research BNB Daily  - Mar 16, 2017 Biocept Inc logo Zacks Investment Research upgraded shares of Biocept Inc  from a sell rating to a buy rating in a research note issued to investors on Friday morning.Roth Capital Reaffirms Buy Rating for Biocept Inc  - Chaffey BreezeRevenue Update on Biocept Inc - Energy Index'
p7
aS"Analyst's Proposition on Biocept, Inc. , W&amp;T Offshore, Inc.  The USA Commerce - Mar 15, 2017 Shares of Biocept, Inc.  surged 3.43% to $2.11. During the trading on 03/14/2017, Company's stock ranged from $2.04 to $2.22."
p8
aS"Buy, Sell or Hold? Analysts Approach: Biocept, Inc. , Avon Products, Inc ... The USA Commerce - Mar 9, 2017 Shares of Biocept, Inc.  surged 0.44% to $2.27. During the trading on 03/08/2017, Company's stock ranged from $2.23 to $2.75.Pay Too Much Attention To Two Stock Analyst Ratings: Biocept, Inc. (NASDAQ ... - The Voice Registrar"
p9
aS'Hot Stocks Report: Biocept, Inc. , Towerstream Corporation  Post Analyst - Mar 17, 2017 Biocept, Inc. has a consensus outperform rating from 2 Wall Street analysts, and the number of shares currently sold short amount to at least 22.56% of shares outstanding.'
p10
a.